DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20150632

Comparison between rapid urease test and carbon 14 urea breath test in the diagnosis of Helicobacter pylori infection

Harmeet Sahni, Karishma Palshetkar, Tanveer Parvez Shaikh, Sharique Ansari, Mithilesh Ghosalkar, Aditya Oak, Naseem Khan

Abstract


Background: The most common human infection of upper gastrointestinal region is Helicobacter pylori. Most individuals remain asymptomatic due to misuse of antibiotic and proton pump inhibitors.  

Methods: 50 patients admitted or on outpatient department basis were selected based on the upper gastrointestinal symptoms and whether they were 18 years and above.

Results: The Rapid Urease Test (RUT) had 84% sensitivity and 91% specificity, with an overall accuracy of 88%. The results of the Urea breath Test (UBT) showed 88% sensitivity and 83% specificity, and an overall accuracy of 85%.

Conclusions: The invasive procedure OGD scopy need not be done in patients for the sole purpose of diagnosing HP infection as the diagnostic efficacies of RUT & UBT tests are similar.


Keywords


Rapid urease test, Carbon 14 urea breath test, Helicobacter pylori, Peptic ulcer

Full Text:

PDF

References


Graham DY, Klein PD, Evans DJ Jr, Evans DG, Alpert LC, Opekun AR, et al. Campylobacter pylori detected noninvasively with C13-urea. Lancet. 1987;1;1174-7.

Raju GS, Smith MJ, Morton D, Bardhan KD. Mini-dose (1-microCi) 14C-urea breath test for the detection of Helicobacter pylori. Am J Gastroenterol. 1994;89:1027-31.

Junaitis LV, Kiudelis G, Kupčinskas L. Evaluation of a novel 14C-urea breath test “Heliprobe” in diagnosis of Helicobacter pylori infection. Medicina (Kaunas). 2001;43(1)32-5.

Abrams DN, Koslowsky I, Matte G. Pharmaceutical interference with the 14C carbon urea breath test for the detection of Helicobacter pylori infection. J Pharm Pharmaceut Sci. 2000;3(2):228-33.

Al-Fadda M, Powe J, Reizeig M, Al Nazer M, Alrajhi AA, Baynton R. Comparison of carbon-14 urea breath test and rapid urease test with gastric biopsy for identification of Helicobacter pylori. Ann Saudi Med. 2000;20(2):170-2.

Rasool S, Abid S, Jafri W. Validity and cost comparison of 14C urea breath test for diagnosis of H. pylori in dyspeptic patients. World J Gastroenterol. 2007;13(6):925-9.

Silvis SE, Nebel O, Rogers G, Sugawa C, Mandelstam P. Endoscopic complications. Results of the 1974 American Society for Gastrointestinal Endoscopy Survey. JAMA. 1976;235:928.

Bentur Y, Matsui D, Koren G. Safety of 14C UBT for diagnosis of Helicobacter pylori infection in pregnancy. Can Fam Physician. 2009;55(5):479-80.

Chan FK, Graham DY. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications - review and recommendations based on risk assessment. Aliment Pharmacol Ther. 2004;19:1051-61.

Hamlet AK, Erlandsson KI, Olbe L, Svennerholm AM, Backman VE, Pettersson AB. A simple, rapid, and highly reliable capsule-based14C urea breath test for diagnosis of Helicobacter pylori infection. Scand J Gastroenterol. 1995;30:1058-63.

Laine L, Estrada R, Trujillo M, Knigge K, Fennerty MB. Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med. 1998;129:547-50.

Bravo LE, Realpe JL, Campo C, Mera R, Correa P. Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection. Am J Gastroenterol. 1999;94:2380-3.

Chey WD, Woods M, Scheiman JM, Nostrant TT, DelValle J. Lansoprazole and ranitidine affect the accuracy of the14C-urea breath test by a pH-dependent mechanism. Am J Gastroenterol. 1997;92:446-50.

Stubbs JB, Marshall B. Radiation dose estimates for the carbon-14-labeled urea breath test. J Nucl Med. 1993;34:821-5.

Leide-Svegborn S, Stenstrom K, Olofsson M, Mattsson S, Nilsson LE, Nosslin B, et al. Biokinetics and radiation doses for carbon-14 urea in adults and children undergoing the Helicobacter pylori breath test. Eur J Nucl Med. 1999;26:573-80.

Boivin C. 13C-urea versus 14C-urea breath test -which is the safer? Nucl Med Commun. 1999;20:978.

Nuclear Radioactive Committee. Radioactive drug: capsules containing carbon-14 urea for “in vivo” diagnostic use for humans. USA: Nuclear Radioactive Committee (NRC); 2014: 10 CFR §30.21.